Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec 1;23(2):113-115.
doi: 10.1097/CND.0000000000000376.

Miller Fisher Syndrome Presenting After a Second Dose of Pfizer-BioNTech Vaccination in a Patient With Resolved COVID-19: A Case Report

Nara Miriam Michaelson  1 , Tiffany Lam  2 , Ashwin Malhotra  1 , Nicholas D Schiff  1 , Daniel James Lysaght MacGowan  1
Affiliations
Case Reports

Miller Fisher Syndrome Presenting After a Second Dose of Pfizer-BioNTech Vaccination in a Patient With Resolved COVID-19: A Case Report

Nara Miriam Michaelson et al. J Clin Neuromuscul Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

References

    1. Repajic M, Lai XL, Xu P, et al. Bell's Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell's palsy. Brain Behav Immun Health. 2021;13:100217.
    1. Martín Arias LH, Sanz R, Sáinz M, et al. Guillain-Barré syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015;33:3773–3778.
    1. Babazadeh A, Mohseni Afshar Z, Javanian M, et al. Influenza vaccination and guillain-barré syndrome: reality or fear. J Transl Int Med. 2019;7:137–142.
    1. Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses. Nature. 2020;586:594–599. Epub 2020 Sep 30. Erratum in: Nature. 2021 Feb;590(7844):E17. PMID: 32998157.

Publication types